Five consecutive quarters—and counting—of declining deal counts in pre-seed and seed-level investments for health technology startups in the U.S.
{iframe}https://www.linkedin.com/pulse/squeeze-continuesearly-stage-health-tech-deal-volume-falls-thomas/{/iframe}